SINOPEC Engineering (SEG) announced its annual results for 2025, with a dividend payout ratio reaching 88%. The company also initiated its first-ever special dividend distribution. Additionally, newly signed orders exceeded the RMB 100 billion mark for the second consecutive year.
Viva Biotech Holdings (1873.HK) announced its annual financial results for 2025, reporting total revenue of RMB 1,729.4 million. The company's net profit saw a significant year-over-year increase of 21.3%, reaching RMB 269.3 million. Gross profit margin improved by 3.3 percentage points to 37.9%, showcasing enhanced…
Read the full storyUnisound (09678.HK) has announced its first audited annual results for the 2025 fiscal year since its listing on the Hong Kong Stock Exchange. The company reported a significant revenue surge of nearly 30%, reflecting robust operational performance across its core segments. Most notably, losses in the second half of…
CStone Pharmaceuticals (HKEX: 2616) has released its annual financial and operational results for 2025, emphasizing a significant expansion of its global commercial footprint. The company reported substantial progress within its Innovation Pipeline 2.0 strategy, focusing on the development of next-generation oncology…
Ping An Healthcare and Technology Company Limited (1833.HK) announced its 2025 annual results, highlighting a massive surge in profitability driven by its corporate services sector. The company recorded total revenue of RMB 5.47 billion, representing a 13.7% increase compared to the previous year. Net profit…
SINOPEC Engineering (SEG) has announced its annual financial results for 2025, highlighted by a significant return of capital to its shareholders. The company reported a record dividend payout ratio of 88%, marking a strong commitment to investor returns. In a historic move, SEG also initiated its first-ever special…